Peripheral blood mononuclear cells enhance sacral wound healing in a patient with spinal cord injury: a case report

Submitted: April 16, 2024
Accepted: November 26, 2024
Published: January 24, 2025
Abstract Views: 51
PDF: 45
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Pressure ulcers are one of the biggest problems in people with Spinal Cord Injury (SCI); this could affect both acute patients and people with chronic SCI, and in the same way bed-ridden patients and people with greater autonomy due to friction and shear mechanisms they are subjected during wheelchair bed transfers. The occurrence of a pressure injury also limits the rehabilitation potential and functional self-recovery. In this case, we reported the story of a 50-year-old man with paraplegia who developed a sacral pressure ulcer in the first days after SCI. Despite the many types of advanced dressings used, the efforts made, the care in positioning, we were unable to close the wound for 5 months. According to plastic surgeons, we decided to use autologous Peripheral Blood Mononuclear Cells (PBMNC) injections to accelerate the process of healing and in a few weeks it led to the complete closure of the sacral wound. PBMNC could be an interesting tool to reduce closing times in addition to advanced dressing; it could be used both in patients during the first period of rehabilitation after SCI and in out-patient settings.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

1. Li Z, Lin F, Thalib L, Chaboyer W. Global prevalence and incidence of pressure injuries in hospitalised adult patients: A systematic review and meta-analysis. Int J Nurs Stud 2020;105. DOI: https://doi.org/10.1016/j.ijnurstu.2020.103546
2. Hajhosseini B, Longaker MT, Gurtner GC. Pressure Injury. Ann Surg 2020;271:671–9. DOI: https://doi.org/10.1097/SLA.0000000000003567
3. Toita R, Shimizu E, Murata M, Kang JH. Protective and healing effects of apoptotic mimic-induced M2-like macrophage polarization on pressure ulcers in young and middle-aged mice. J Controlled Release 2021;330:705–14. DOI: https://doi.org/10.1016/j.jconrel.2020.12.052
4. Gurevich DB, Severn CE, Twomey C, et al. Live imaging of wound angiogenesis reveals macrophage orchestrated vessel sprouting and regression. EMBO J 2018;37:e97786. DOI: https://doi.org/10.15252/embj.201797786
5. Martin P, Gurevich DB. Macrophage regulation of angiogenesis in health and disease. Semin Cell Dev Biol 2021;119:101–10. DOI: https://doi.org/10.1016/j.semcdb.2021.06.010
6. Rehak L, Giurato L, Meloni M, et al. The immune-centric revolution in the diabetic foot : monocytes and lymphocytes role in wound healing and tissue regeneration — a narrative review. J Clin Med 2022;11:889. DOI: https://doi.org/10.3390/jcm11030889
7. Di Pardo A, Cappello E, Pepe G, et al. Infusion of autologous-peripheral blood mononuclear cells : a new approach for limb salvage in patients with diabetes. In: 7th International Diabetic Foot Congress abu Dhabi. IFD Congress Abu Dhabi 4-8 December 2017; 2017. p. International Diabetic Foot Congress Abu Dhabi 4-8.
8. Proto JD, Doran AC, Gusarova G, et al. Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 2018;49:666-77.e6. DOI: https://doi.org/10.1016/j.immuni.2018.07.015
9. Nosbaum A, Prevel N, Truong HA, et al. Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing. J Immunol 2016;196:2010–4. DOI: https://doi.org/10.4049/jimmunol.1502139
10. Li J, Tan J, Martino MM, Lui KO. Regulatory T-cells: Potential regulator of tissue repair and regeneration. Front Immunol 2018;9:585. DOI: https://doi.org/10.3389/fimmu.2018.00585
11. Danon D, Kowatch MA, Roth GS. Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 1989;86:2018-20. DOI: https://doi.org/10.1073/pnas.86.6.2018
12. Zuloff-Shani A, Kachel E, Frenkel O, et al. Macrophage suspensions prepared from a blood unit for treatment of refractory human ulcers. Transfus Apher Sci 2004;30:163–7. DOI: https://doi.org/10.1016/j.transci.2003.11.007
13. Zuloff-Shani A, Adunsky A, Even-Zahav A, et al. Hard to heal pressure ulcers (stage III-IV): Efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial. Arch Gerontol Geriatr 2010;51:268–72. DOI: https://doi.org/10.1016/j.archger.2009.11.015
14. Rigato M, Monami M, Fadini GP. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Vol. 120, Circulation Research. Lippincott Williams and Wilkins; 2017. p. 1326–40. DOI: https://doi.org/10.1161/CIRCRESAHA.116.309045
15. Spaltro G, Straino S, Gambini E, et al. Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesis. Cytotherapy 2015;17:1302–13. DOI: https://doi.org/10.1016/j.jcyt.2015.04.006

How to Cite

delli Santi, G., Pilati, C., Borgognone, A., & Tiberti, S. (2025). Peripheral blood mononuclear cells enhance sacral wound healing in a patient with spinal cord injury: a case report. Italian Journal of Wound Care, 8(3). https://doi.org/10.4081/ijwc.2024.113

Similar Articles

<< < 1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.